ESC 365 - J-point elevation in subjects with TWI V1-V4 does not differentiate between arrhythmogenic right ventricular cardiomyopathy (ARVC) and healthy athletes when matched for age, sex and ethnicity.

ESC Premium Access

J-point elevation in subjects with TWI V1-V4 does not differentiate between arrhythmogenic right ventricular cardiomyopathy (ARVC) and healthy athletes when matched for age, sex and ethnicity.

Session: Management of athletes with heart disease

Topic: Sports cardiology

Speaker: Doctor M. Brosnan (Melbourne, AU)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Maria Brosnan

St Vincent's Hospital, Melbourne (Australia)

1 presentation

0 follower

3 more presentations in this session

State of the Art: management of athletes with heart disease

Speaker: Professor S. Sharma (London, GB)

Prevalence and clinical outcome of arrhythmic mitral valve prolapse in athletes

Speaker: Doctor S. Caselli (Zurich, CH)

Legal aspects of disqualification recommendations for elite athletes with cardiovascular disease

Speaker: Professor B. Merkely (Budapest, HU)

Access the full session

Management of athletes with heart disease

Speakers: Doctor M. Brosnan, Professor S. Sharma, Doctor S. Caselli, Professor B. Merkely

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources